학술논문
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Document Type
article
Author
Semb, Anne Grete; Rollefstad, Silvia; Ikdahl, Eirik; Wibetoe, Grunde; Sexton, Joseph; Crowson, Cindy; van Riel, Piet; Kitas, George; Graham, Ian; Rantapää-Dahlqvist, Solbritt; Karpouzas, George Athanasios; Myasoedova, Elena; Gonzalez-Gay, Miguel A; Sfikakis, Petros P; Tektonidou, Maria G; Lazarini, Argyro; Vassilopoulos, Dimitrios; Kuriya, Bindee; Hitchon, Carol; Stoenoiu, Maria Simona; Durez, Patrick; Pascual-Ramos, Virginia; Galarza-Delgado, Dionicio Angel; Faggiano, Pompilio; Misra, Durga Prasanna; Borg, Andrew A; Mu, Rong; Mirrakhimov, Erkin M; Gheta, Diane; Douglas, Karen; Agarwal, Vikas; Myasoedova, Svetlana; Krougly, Lev; Popkova, Tatiana Valentinovna; Tuchyňová, Alena; Tomcik, Michal; Vrablik, Michal; Lastuvka, Jiri; Horak, Pavel; Medkova, Helena Kaspar; Kerola, Anne M
Source
RMD Open. 7(2)
Subject
Language
Abstract
The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention. The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014-2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM. The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p